Homebiotech

biotech

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026

biotech

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Jim Cornall - June 25, 2026

biotech

Meteor Biotech joins brain organoids consortium

Jim Cornall - June 25, 2026

biotech

Can food influence gene activity?

Jim Cornall - June 24, 2026

biotech

A new path in cancer immunotherapy

Jim Cornall - August 6, 2025

biotech

Dx&Vx signs co-development and license agreement for mRNA cancer vaccine

Jim Cornall - August 5, 2025

biotech

Fast Track designation for severe alopecia areata treatment

Jim Cornall - August 5, 2025

biotech

Boehringer Ingelheim and Re-Vana Therapeutics to collaborate on ophthalmic therapies

Jim Cornall - August 5, 2025

biotech

MapLight Therapeutics raises $372.5m

Jim Cornall - August 4, 2025

biotech

Positive results for Energenesis Biomedical Parkinson’s disease treatment

Jim Cornall - August 4, 2025

biotech

Biotech tests in space?

Jim Cornall - August 4, 2025

biotech

Base to Base biotech podcast 20: Terumo BCT boosts CAR-T cell manufacturing, and Orbis on macrocycles

Jim Cornall - August 1, 2025

1...697071...85 Page 70 of 85

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026 0

Vedana Therapeutics, a biotechnology company developing next-generation therapies for migraine prevention, has emerged from stealth with $46m in Series A financing. The financing was co-led...

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

biotech Jim Cornall - June 25, 2026 0

Meteor Biotech joins brain organoids consortium

biotech Jim Cornall - June 25, 2026 0

Can food influence gene activity?

biotech Jim Cornall - June 24, 2026 0

Lab-engineered proteins: a promising treatment for liver disease

biotech Jim Cornall - June 24, 2026 0